Search results
Teachers Retirement System of The State of Kentucky Sells 1,245 Shares of Regeneron Pharmaceuticals,...
ETF DAILY NEWS· 9 hours agoTeachers Retirement System of The State of Kentucky cut its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.7% during the 4th ...
Oracle Alpha Inc. Buys New Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 2 days agoOracle Alpha Inc. purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the fourth quarter, Holdings ...
Jacobi Capital Management LLC Boosts Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 4 days agoJacobi Capital Management LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 10.5% in the 4th quarter, HoldingsChannel ...
Investors in Regeneron Pharmaceuticals (NASDAQ:REGN) have seen stellar returns of 220% over the past...
Simply Wall St. via Yahoo Finance· 2 days agoBut on a lighter note, a good company can see its share price rise well over 100%. Long term ...
Analyst Report: Regeneron Pharmaceuticals, Inc.
Morningstar Research via Yahoo Finance· 2 days agoRegeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The ...
...Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN - ...
Benzinga· 1 day agoNEW YORK, June 15, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ:REGN). Such investors are
Regeneron, Sanofi Get Expanded FDA OK for Kevzara in Polyarticular Juvenile Idiopathic Arthritis
Morningstar· 5 days agoBy Colin Kellaher Regeneron Pharmaceuticals and Sanofi have won expanded Food and Drug Administration approval of their arthritis drug Kevzara for certain ...
RBC lifts Regeneron stock PT to $1,229 on higher sales estimetes of Dupixent By Investing.com
Investing.com· 4 days agoOn Wednesday, Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) saw an increase in its price target to...
Regeneron (REGN), SNY Win FDA Nod for Kevzara Label Expansion
Zacks via Yahoo Finance· 5 days agoRegeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced that the FDA has approved a...
...Dupixent COPD Sales To Reach $20B By 2026, Analyst Sees Larger Addressable Market - Regeneron ...
Benzinga· 3 days agoAnalyst projects Regeneron's Dupixent to drive COPD sales surge, envisioning $20B market by 2026 on larger addressable market.